Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial

Nicole van der Wielen*, Freek Daams, Riccardo Rosati, Paolo Parise, J. rgen Weitz, Christoph Reissfelder, Ismael Diez del Val, Carlos Loureiro, Purificación Parada-González, Elena Pintos-Martínez, Francisco Mateo Vallejo, Carlos Medina Achirica, Andrés Sánchez-Pernaute, Adriana Ruano Campos, Luigi Bonavina, Emanuele L. G. Asti, Alfredo Alonso Poza, Carlos Gilsanz, Magnus Nilsson, Mats LindbladSuzanne S. Gisbertz, Mark I. van Berge Henegouwen, Uberto Fumagalli Romario, Stefano de Pascale, Khurshid Akhtar, H. Jaap Bonjer, Miguel A. Cuesta, Donald L. van der Peet*, Jennifer Straatman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Introduction: Minimally invasive techniques show improved short-term and comparable long-term outcomes compared to open techniques in the treatment of gastric cancer and improved survival has been seen with the implementation of multimodality treatment. Therefore, focus of research has shifted towards optimizing treatment regimens and improving quality of life. Materials and methods: A randomized trial was performed in thirteen hospitals in Europe. Patients were randomized between open total gastrectomy (OTG) or minimally invasive total gastrectomy (MITG) after neoadjuvant chemotherapy. This study investigated patient reported outcome measures (PROMs) on health-related quality of life (HRQoL) following OTG or MITG, using the Euro-Qol-5D (EQ-5D) and the European Organization for Research and Treatment of Cancer (EORTC) questionnaires, modules C30 and STO22. Due to multiple testing a p-value < 0.001 was deemed statistically significant. Results: Between January 2015 and June 2018, 96 patients were included in this trial. Forty-nine patients were randomized to OTG and 47 to MITG. A response compliance of 80% was achieved for all PROMs. The EQ5D overall health score one year after surgery was 85 (60–90) in the open group and 68 (50–83.8) in the minimally invasive group (P = 0.049). The median EORTC-QLQ-C30 overall health score one year postoperatively was 83,3 (66,7–83,3) in the open group and 58,3 (35,4–66,7) in the minimally invasive group (P = 0.002). This was not statistically significant. Conclusion: No differences were observed between open total gastrectomy and minimally invasive total gastrectomy regarding HRQoL data, collected using the EQ-5D, EORTC QLQ-C30 and EORTC-QLQ-STO22 questionnaires.
Original languageEnglish
JournalEuropean Journal of Surgical Oncology
Early online date2021
DOIs
Publication statusE-pub ahead of print - 2021

Cite this